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Abstract
The conformation of HIV-1 envelope (Env) glycoprotein trimers is key in ensuring protection
against waves of neutralizing antibodies generated during infection, while maintaining suffi-
cient exposure of the CD4 binding site (CD4bs) for viral entry. The CD4 binding loop on Env
is an early contact site for CD4 while penetration of a proximal cavity by CD4 triggers Env
conformational changes for entry. The role of residues in the CD4 binding loop in regulating
the conformation of the trimer and trimer association domain (TAD) was investigated using
a novel saturation mutagenesis approach. Single mutations identified, resulted in distinct
trimer conformations affecting CD4bs exposure, the glycan shield and the TAD across
diverse HIV-1 clades. Importantly, mutations that improve access to the CD4bs without
exposing the immunodominant V3 loop were identified. The different trimer conformations
identified will affect the specificity and breadth of nabs elicited in vivo and are important to
consider in design of Env immunogens for vaccines.
Author Summary
Spike proteins on the surface of HIV virus particles bind to CD4 receptors on the surface
of immune cells and trigger infection. The immune system in an infected person attacks
the virus spikes by producing antibodies that bind and neutralize them. To combat this
immune attack, HIV continually alters the structure of the spike and thus escapes host
antibodies. However, this process must still preserve sites on the spike that bind CD4
receptors for infection.Here, we investigated how the spike regulates its structure.We
used a systematic approach to investigate every possible mutation covering a region of the
spike critical for binding the CD4 receptor and controlling overall structure.We identified
different sites and mechanisms that control the spike structure for diverse HIV-1 strains
and impact the exposure of the binding site for CD4 along with targets for neutralizing
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antibodies. Our observationswill help guide the design of spike structures for vaccines
that induce neutralizing antibodies effective against different HIV-1 strains across the
globe.
Introduction
The HIV-1 envelope glycoprotein (Env) comprises a surface gp120 and a transmembrane gp41
non-covalently associated on heterodimeric trimers.When gp120 on the Env trimer binds
CD4 at the cell surface, conformational changes are triggered that open the trimer to expose a
site for binding to a coreceptor, usually CCR5. Trimer opening involves the disengagement of
the trimer association domain (TAD) at the trimer apex enabling (1) movement of the V1V2
loops to expose the V3 loop and (2) full exposure of determinants on the V1V2 stem recruited
by CD4 to assemble the bridging sheet. The V3 loop and sections of the bridging sheet form
the coreceptor binding site [1].
The CD4 binding loop on Env is an early contact site for CD4 [2], while penetration of a
proximal cavity by the hydrophobic side chain of CD4’s Phe-43 triggers Env conformational
changes and trimer opening [3–5] (Fig 1). For example, an S375W substitution in Env results
in the organic side chain of the tryptophan accessing the cavity and directing a more open Env
conformation [4, 5].
HIV-1 Envs in brain tissue use CCR5 as a coreceptor and are highly macrophage-tropic.
These Env variants interact efficiently with low CD4 levels on macrophages for infection [6, 7].
Determinants that modulate mac-tropism of R5 Envs lie within or proximal to the CD4bs [8,
9] as well as in V1V2 and V3 loops of the TAD [8, 10, 11]. They include residues within the
variable N-terminal flank of the CD4 binding loop that together with V3 loop amino acids
modulatedmac-tropism in a highly mac-tropic brain Env from a subject with neurological
complications [8].
Here, a novel saturation mutagenesis approach; EMPIRIC (ExceedinglyMeticulous and
Parallel Investigation of Randomized Individual Codons) was exploited to investigate individ-
ual residues in a 20 amino acid region encompassing the CD4 binding loop (Fig 1A and 1F),
for effects on replication and Env conformation. This 20 residue region includes conserved res-
idues that contact CD4 (Fig 1B and 1C) and/or form part of the Phe-43 cavity (Fig 1D and 1E).
EMPIRIC involves the generation of libraries of mutations encoding all possible individual
amino acid substitutions across important regions of genes [13–18]. Libraries are subject to
selection or competition before analyzing by deep sequencing to quantify the frequency change
of each mutation. Using EMPIRIC, substitutions in the CD4 binding loop and flanks were suc-
cessfully identified that conferred enhanced or wt levels of replication in peripheral blood
mononuclear cells (PBMCs). Several substitutions modulated the Env trimer with different
mutations imparting distinct conformations that enhanced the exposure of the CD4bs but had
varying effects on the TAD including the V3 loop and the glycan shield. One mutation
enhanced the presentation of the quaternary trimer specific,V1V2 epitope (V2q) on the trimer
apex that is recognizedby PG9, PG16 and PGT145 monoclonal antibodies (mabs), consistent
with a modified but closed trimer conformation. The effects of the different mutations were
transferable to diverse clade B and C Envs. These observations confirm the capacity of
EMPIRIC to identify single Env residues in the CD4 binding loop region that induce different
conformational states in the TAD and trimer. This data is relevant for design of trimeric Env
immunogens in vaccines that aim to protect against diverse HIV-1 clades.
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Fig 1. The HIV-1 envelope trimer structure. Structures shown were derived from PDB 4NCO [12]. (A) Side
view of trimer depicted as a cartoon showing the location of the target sequences of two EMPIRIC libraries
that span the CD4 binding loop and flanks and comprise residues 361–370 (yellow spheres) and 371–380
(green spheres). (B,C,D,E) Residues 361–370 (B,D) and 371–380 (C,E) are shown as spheres. (B-C) Red
amino acids indicate CD4 contact residues. (D-E) Both blue and red spheres surround the Phe-43 cavity,
with the red spheres indicating those that directly contact Phe-43 [2]. (F) CD4 binding loop residues 361–380
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Results
The primary LN40 Env and saturation libraries
Saturation mutant libraries were introduced into the primary LN40 Env [8, 19, 20]. LN40 env
was PCR amplified and cloned from the lymph node of an AIDS patient with neurological
complications. The LN40 R5 Env is not mac-tropic and is typical of Envs from immune tissue
throughout disease [6, 21–23]. Most transmitted, founder R5 Envs are also not mac-tropic
[24–27]. LN40 and other non-mac-tropic R5 Envs may form tightly closed trimers that protect
against neutralizing antibodies (nabs) [28, 29]. Determinants of LN40 non-mac-tropism were
previously mapped to residues on the N-terminal flank of the CD4 binding loop in addition to
residues within V3. Presumably, these residues reduce access to CD4 (as well as nabs) and
restrict replication to T-cells expressing high CD4 levels [8, 19, 20, 30]. It was predicted that
mutations in the CD4 binding loop, its flanks and Phe-43 cavity would have strong potential to
increase viral fitness by enhancing efficiencyof Env/CD4 interactions [5, 8, 20, 31].
Two plasmid libraries were made containing all possible point mutations for Env amino
acids 361–380 (361–370 and 371–380 in each library (SeeMovie at https://vimeo.com/
165897330, password: Mama8) of LN40 env in full length, replication competent, pNL4.3 [21].
The vast majority of the mutants were present in the plasmid libraries and virions (P0) pro-
duced by transfection of 293T cells (S1A and S1B Fig). The frequency of most mutants in plas-
mid and P0 libraries was well above the background from all processing steps including RT,
estimated by sequencing virus recovered from a plasmid with wt env (S1D Fig). The frequency
of mutants in the P0 library correlated highly with that in plasmid library, indicating that P0
library recovery by transfection achieved a good sampling of mutants in the plasmid library
(S1E Fig).
Bulk competition of mutant libraries in PHA/IL-2 stimulated PBMCs
P0 viruses of each library were competed in bulk for amplification in PBMCs (S2A Fig). This
process selects for viruses carryingwt and mutant Envs that are functional, but will overlook
Envs carryingmutations that abrogate replication or that confer suboptimal replicative capac-
ity. Nevertheless, this selection process enabled us to focus solely on mutations that did not
have deleterious effects on replication. The abundance of each mutant was measured before
and after amplification using Illumina deep sequencing and fitness estimated (seeMaterials
and Methods). Stop codons were consistently depleted in both libraries (S2B Fig). Allwt-syno-
nyms in library-371-380 displayed wt-like fitness effects, although slightly more variation in fit-
ness effects of wt -synonyms in library-361-370 was noted.
Following 8 days of infection, a strong correlation between enrichment and depletion of
mutants in replicates was observed in library-371-380, but a weaker correlation between repli-
cates in library-361-370 (S2D Fig). One explanation for the difference in reproducibility is that
the virus stock containing library-361-370 had less infectivity compared to the stock containing
library-371-380, and thus fewer virions mediated infection of PBMC. It was therefore more
prone to insufficient sampling of P0 library, perhaps leading to stochastic enrichment or deple-
tion of mutants.
Despite slightly higher variation in library-361-370, the results indicate that the majority of
selectionwas reproducible and caused by introducedmutations. Data from the two replicates
were pooled to obtain more precise measurements for analysis (S1 Table). The fitness effect of
for clade B Envs, LN40, LN8 and clade C Env Z1792M. Stars denote CD4 contact residues, circles denote
residues that line the Phe-43 cavity.
doi:10.1371/journal.ppat.1005988.g001
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each amino acid was compared to that of repeatedly resampled wt -synonyms and an empirical
p value of each amino acid computed for a fitness effect no different to that of wt -synonyms
(Materials and Methods). After applying a 5% false discovery rate (FDR) as a multiple test cor-
rection,mutations were classified as statistically beneficial (significantly higher fitness than wt,
synonyms), or statistically deleterious (significantly lower fitness than wt, synonyms), or statis-
ticallywt-like (neither beneficial nor deleterious) (S1 and S2 Tables). The majority of mutations
in both libraries were strongly deleterious, indicating the 2 regions are extremely sensitive to
missensemutations.
Both libraries had a limited number of mutants with wt -like fitness or above (S1 and S2
Tables; Fig 2A). Library-361-370 contained more fit mutations (19%) compared to library-
371-380 (16%) even though it has less overall infectivity. This is also consistent with an
increased variability of amino acids N-terminal to the CD4 contact residues on the HIV-1
(http://www.hiv.lanl.gov/content/sequence/HIV/mainpage.html).No other amino acids except
wt residues were fully functional in CD4 contact residues (GGD368_E370) (Fig 2B and 2C). In
Fig 2. EMPIRIC analysis of the CD4 binding loop and flanks of LN40 Env and categorization of mutations as beneficial, wt or
deleterious. (A) Most mutations were deleterious. However, subsets of mutations that imparted wt or higher levels of replication were
identified. (B) The overall fitness effect of each substitution (average fitness effects at each position) is shown by designated colors (see
key). Mutations that affect CD4 contact residues (marked with asterisks) were strongly deleterious. However, twelve mutations in regions
downstream of the CD4 contact residues dramatically increased the efficiency of viral replication. These residues are proximal to the Phe-
43 cavity. (C) The most common amino acids in positions 361–380 following PBMC passage of the two libraries (upper panel). The most
common amino acids in positions 361–380 in all subtypes in the patient sequence database (http://www.hiv.lanl.gov/content/sequence/
HIV/mainpage.html) (lower panel). The corresponding LN40 amino acid sequence is shown below the lower panel.
doi:10.1371/journal.ppat.1005988.g002
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contrast, substitutions of proline at position P369 to cystidine, alanine, glutamine and aspartic
acid conferredwt -like fitness. Positions 361–365 were more tolerant of mutations, especially
positions 362 and 363, where the wt amino acids are asparagine and glutamine respectively.
Charged amino acids (except for histidine) were well tolerated at these two positions (Fig 2B
and 2C). At position 365, the wt is serine, whereas valine and alanine exhibited slightly
increased fitness, although this was not significant.
In the 371–380 library, positions 373, 375 and 377 were tolerant of mutations. Even residues
carrying side chains with different structures were at least wt -like in fitness (Fig 2B and 2C).
For example, at position 373, glutamic acid was strongly beneficial over wt arginine. At position
375, where the wt amino acid is serine, all amino acids with aromatic rings as well as threonine
and histidine were strongly beneficial.Glycine is the wt residue at position 380, and is relatively
conserved in natural isolates (Fig 2C). Proline was slightly beneficial at 380. Positions 371, 372,
374, 376 and 378 were resistant to change, although substitutions to amino acids with very sim-
ilar structures (e.g. Ile/Val and Phe/Tyr) were tolerated at some positions e.g. 371 and 376.
Overall, 13 beneficialmutations were identified, all in library-371-380 (S2 Table). Although
a fewmutations in library-361-370 exhibited small positive fitness effects, they were not statis-
tically significant. This could be partly attributable to higher variation of fitness measurements
in this library (due to lower overall infectivity) leading to reduced statistical power and/or to
the optimal adaptation of this region to its function. All beneficialmutations in library-371-
380 have a greater than 15% increase in fitness, which is very large compared to EMPIRIC
studies in other systems [15].
Fitness benefit and wt mutations identified by EMPIRIC result in
changes in LN40 Env conformation and function
33 mutations that mostly conferred increased or wt levels of replication in PBMCs were investi-
gated to elucidate effects on Env conformation (Table 1). The frequency of these mutant amino
acids among the major HIV-1 subtypes are shown in S3 Table.
Each mutation was introduced into the pSVIIIenv Env expression construct carrying
LN40 env, before producing Env+ pseudoviruses (Materials and Methods). Changes in Env
conformation were evaluated by testing sensitivity LN40 Env+ pseudovirions to inhibition
by soluble CD4 (sCD4) and Env monoclonal antibodies (mabs) including CD4bs mabs, b6,
b12, V3 loop mab, 447-52D, the glycan specific 2G12, V3 specific PGT128 and CD4i mab,
17b (Table 1).
Increases in sCD4 sensitivity. LN40 is relatively resistant to sCD4 inhibition due either to
steric restrictions to binding and/or to resistance to CD4-induced conformational changes
[30]. Sharp increases in sCD4 sensitivity for mutant Envs are consistent with changes in Env
conformation that enhance CD4 interactions. Substitutions that increased sCD4 sensitivity
included several at residue 375 e.g. S375W. Residue 375 is proximal to the Phe-43 cavity and
S375Wwas reported to increase Env sampling of the CD4-bound form in gp120 monomers
[5]. Substitutions at residues 373 (R373E), 377(N377V) and 380 (G380P) also conferred
increases in sCD4 sensitivity. Other substitutions had less or no effect on sCD4 sensitivity
(Fold change in IC50s are shown in Table 1 with IC50s in S4 Table).
Increases in sensitivity to CD4bs mabs. LN40 is resistant to the CD4bs mab b12. The b12
epitope is present on monomeric LN40 gp120 but occluded on the trimer [30]. Five substitu-
tions at residue 373 (373E, 373M, 373N, 373Q and 373K) increased LN40 sensitivity to b12.
This observation is not surprising since it was previously reported that the side chain of R373
(together with the glycan at N386) sterically restrictedW100 of b12 from accessing a pocket on
gp120 for binding [20].
HIV-1 Envelope CD4 Binding Loop Residues Control Distinct Trimer Conformations
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All substitutions at 373 with a shorter side chain than arginine might be expected to expose
theW100 pocket for b12 [20]. Substitutions Q363E and Q363D also conferred sensitivity to
b12. These negatively charged residues may alter the structure of the b12W100 pocket (e.g. by
moving the glycan at N386) so that it is now open. Decreased 2G12 sensitivity supports a shift
in the glycan shield including the glycan at N386, a 2G12 target [19]. The same 363 and 373
Table 1. The effect of LN40 mutations identified by EMPIRIC on Env structure and function. Neutralization assays were used to assess changes in
Env structure and function
LN40 Env wt and mutants sCD4 447-52D-V3 crown b6-CD4bs b12-CD4bs 17b-CD4i PGT128 2G12-glycans
IC50 fold change from LN40wt
LN40 wt 1.00 1.00 1.00 1.00 1.00 1.00 1.00
361 F361I d1 1.02 1.22 1.00 0.70 nt 1.14 1.68
F361L d 1.00 1.16 1.00 0.86 nt 1.14 1.49
F361Y w 1.40 1.33 1.00 0.70 nt 1.00 2.74
362 N362D w 1.25 1.18 1.00 1.18 nt 1.00 0.56
N362E w 1.00 1.37 1.00 0.70 nt 1.00 1.49
N362K w 1.00 1.85 1.00 0.70 nt 1.14 4.73
N362S w 1.00 0.80 1.00 0.70 nt 1.33 2.74
N362T w 1.00 2.00 1.00 0.70 nt 1.00 2.60
N362A d 1.00 0.80 1.00 0.70 nt 1.14 2.74
363 Q363D w 1.36 2.25 1.00 7.76 nt 1.00 0.47
Q363E w 1.44 2.21 1.00 13.96 nt 1.14 0.49
Q363G d 1.00 1.36 1.00 0.70 nt 1.14 0.83
Q363H d 1.84 2.76 1.00 0.70 nt 1.00 0.85
3652 S365A w 1.56 1.84 1.00 0.70 nt 0.89 1.04
S365V w 1.12 1.40 1.00 0.70 1.00 1.00 1.00
369 P369A w 1.00 0.80 1.00 0.70 nt nt 0.58
P369C w 1.00 0.80 1.00 0.70 nt nt 1.02
P369D w 1.00 1.54 1.00 0.70 nt nt 0.37
P369E w 1.00 1.38 1.00 0.70 nt nt 0.52
3712 R371V w 1.00 0.80 1.00 1.01 nt 0.80 1.04
373 R373K b 1.00 1.14 1.00 12.46 nt 0.89 0.63
R373M w 1.00 0.80 1.00 31.73 nt 0.89 0.69
R373Q b 1.13 1.59 1.00 23.27 nt 0.67 0.35
R373E b 2.09 16.67 1.00 17.45 1.00 0.67 0.20
R373N b 1.14 3.10 1.00 10.26 1.00 0.80 0.53
375 S375H b 3.27 0.80 1.00 0.7 nt 0.57 0.33
S375T b 1.31 0.80 1.00 1.03 nt 0.89 0.62
S375F b 6.58 0.80 1.00 0.70 nt 0.62 0.24
S375W b 5.75 0.80 1.00 0.82 1.00 0.57 0.16
S375Y b 8.47 0.80 1.00 0.77 1.00 0.80 0.17
377 N377V b 2.63 30.77 1.00 0.85 1.00 0.80 0.42
380 G380A w 1.56 >200.0 1.49 1.30 1.00 0.80 0.46
G380P b 2.30 >200.0 3.27 1.38 1.00 0.40 0.20
1. b, beneficial; w, wt-like; d, deleterious substitutions.
2. CD4 contact residues.
nt; not tested.
green, >2,<4-fold; yellow, >4<100-fold; red, >100-fold differences.
doi:10.1371/journal.ppat.1005988.t001
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substitutions also impacted the TAD as detected by increases in 447-52D sensitivity indicating
a more exposedV3 loop.
Mab b6 also targets the CD4bs. However, its epitope is occluded on primary Envs [7, 32].
Here, b6 failed to neutralize any mutant, except for G380A and G380P, which conferred weak
sensitivity. This indicates that other substitutions tested did not sufficiently open the trimer to
enable b6 binding.
Increased sensitivity to 447-52D and V3 loop exposure. Mab 447-52D recognizes a
GPGRmotif on the V3 crown which is occludedwithin the trimers of most primaryHIV-1
strains, including LN40.
Substitutions that increased sensitivity to 447-52D, indicating a more exposedV3 loop,
included Q363D, Q363E, Q363H, R373E and R373N. Substitutions at 377 (N377V) and 380
(G380A and G380P) also conferred enhanced sensitivity to 447-52D as well as to sCD4, consis-
tent with a larger impact on the TAD. G380A and G380P mutants were exquisitely sensitive to
447-52D implying a more dramatic shift in the TAD and V3 loop exposure. In contrast, substi-
tutions at residue 375 (e.g. S375W, S375Y and S375F) that conferred increased sCD4 sensitiv-
ity, remained resistant to 447-52D, indicating that the V3 loop was not exposed and that these
changes induced a distinct trimer conformation.
Decreasedsensitivity to 2G12 indicates a shift in the glycan shield. All the substitutions
that increased sensitivity to sCD4 and/or CD4bs and V3 loopmabs also had modestly
increased resistance to the glycan specificmab, 2G12, consistent with a change in the trimer
conformation that shifts the orientation of the glycan shield.
Env mutants do not carry an exposedCD4i epitope. We focused on substitutions at 373,
375, 377 and 380, which imparted the most significant shifts in Env conformation and tested
their sensitivity to the CD4i mab, 17b [2, 33]. We first confirmed that the epitope for mab 17b
is present on LN40 by measuring binding to purified gp120 in the presence and absence of
sCD4 (S3A Fig). It is unlikely that the librarymutations themselves would affect the 17b epi-
tope, which is focused on a distal bridging sheet site [2]. In neutralization assays, LN40 wt and
each of the 373, 375, 377 and 380 substitutions were resistant to neutralization by 17b, thus
indicating that changes in trimer conformation for these mutant Envs did not expose the CD4i
epitope.
Several different residues substituted at P369 impart wt LN40 replication. CD4 contact
residues, GGD368_E370, in the CD4 binding loop were not readily substituted. However, muta-
tions that substituted P369 with A, C, D and E residues imparted wt-like replication. P369 is
relatively conserved in clade B Envs and its replacement with other amino acids might be
expected to confer properties selected against in vivo. However, 369 mutants carryingA, C, D
E, did not exhibit differences in sensitivity to sCD4, 447-52D, b6 or b12, while only D and E
slightly decreased sensitivity to 2G12. These results indicated that this position accepts several
different amino acids without detectable changes in Env conformation or replication fitness.
Summary of LN40 mutants. The use of multiple neutralizingmabs to investigate each
substitution allowed an assessment of the changes distal to the residue in question and in over-
all Env conformation. The data presented show that different residues within or closely associ-
ated with the Phe-43 cavity have distinct effects on the conformation of the TAD and trimer.
The effect of introducing an N160 glycan into LN40 Env
V2q mabs, PG9, PG16 and PGT145 bind the V2 glycan N160 and preferentially recognize the
TAD at the apex of trimers rather than monomers. These mabs can be used as probes to assess
whether this site has been disrupted consistent with trimer opening [30, 34]. Unfortunately,
LN40 Env does not carry the N160 glycan, critical for binding V2q mabs, although a glycan at
HIV-1 Envelope CD4 Binding Loop Residues Control Distinct Trimer Conformations
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N156, also targeted by V2q mabs, is present. The N160 potential N-linked glycosylation signal
was restored to LN40 Env by mutagenesis in the hope of reconstituting V2q mab binding.
However, LN40 Y160N remained resistant to V2q mabs PG9, PG16 and PGT145 (S3B Fig)
and presumably doesn’t bind these mabs.
Nevertheless, the introduction of N160 conferred increased sensitivity to sCD4 (Fig 3A, S5
and S6 Tables), consistent with a TAD conformation that enhances access to the CD4bs. Sev-
eral substitutions identified by EMPIRIC conferred further enhancement in sensitivity to
sCD4, the V3 mab 447-52D and CD4bs mab b6 when introduced together with Y160N (Fig
3A–3C, S5 and S6 Tables). In particular, LN40 160N mutants, 375W and, were more sensitive
to sCD4 compared to Env mutants without Y160N. The presence of N160 also enhanced sensi-
tivity of 377V to V3-specific 447-52D and more modestly to b6 (Fig 3B and 3C, S5 and S6
Tables). In contrast, the LN40 160N 375Wmutant was only modestly more sensitive to sCD4
and remained relatively resistant to both 447-52D and b6.
These data indicate that the N160 glycan on LN40 conferred a trimer conformation where
the CD4bs site is more exposed enabling enhanced interactions with CD4 and antibodies tar-
geting V3 and the CD4bs.
Mutations that change LN40 Env conformation conferred similar effects
on another clade B Env and a clade C transmitter, founder Env
Severalmutations were introduced into another clade B Env, LN8, and into a clade C Env,
Z1792M. LN8 is an R5 envelope derived by PCR cloning from the lymph node of subject
NA20, who died of AIDS with neurological disease [6, 21], while Z1792M is a transmitter,
founder, clade C R5 Env from Zambia [35].
Substitutions at residue S375. Substitutions S375H and S375W both enhanced sCD4 sen-
sitivity of LN8 and clade C, Z1792M, as they did for LN40 (Fig 4A; S7–S10 Tables). These S375
substitutions had little effect on LN8 sensitivity to b12, b6 and 447-52D, yet conferredmore
resistance to 2G12. This is consistent with a shift in the orientation of one or more glycans
resulting in a more exposedCD4bs and increased sCD4 sensitivity. The changes implicated in
LN8 Env conformation closely follow those described above for LN40 Env. Z1792M does not
Fig 3. The effect of the Y160N substitution on LN40 wt and mutant Envs on sensitivity to sCD4 (A), V3 loop mab, 447-52D (B)
and CD4bs mab, b6 (C).
doi:10.1371/journal.ppat.1005988.g003
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carry the b12, 447-52D or 2G12 epitopes. However, S375 substitutions had no effect on b6
resistance.
The N377V substitution. N377V conferred increased sensitivity to sCD4 for LN8 and
Z1792M and modestly increased sensitivity of LN8 to V3 mab, 447-52D, following observa-
tions made for the equivalent LN40 mutant (Fig 4A and 4B).
Substitutions at G380. G380P enhanced sCD4 and b6 sensitivity for LN8 and conferred
exquisite sensitivity to the V3 mab, 447-52D. G380P also rendered LN8 highly sensitive to mab
b12, in contrast to LN40 where there was no effect. In addition, G380P enhanced sensitivity to
sCD4 and b6 for Z1792M (Fig 4, S7–S10 Tables). These results indicate that G380P conferred
more dramatic changes to the trimer conformation of LN40, LN8 and Z1792M Envs resulting
in improved CD4 interactions and enhanced exposure of the V3 loop (at least for LN40 and
LN8) and b6 epitope, consistent with a more open trimer conformation. Together, these find-
ings indicate that substitutions at 375, 377 and 380 enhance Env/CD4 interactions across two
diverse clades.
L369P substitution in clade C Z1792M Env. P369 is conserved on the clade B database,
while L369 is dominant for clade C. A L369P substitution was made in clade C, Z1792M Env.
Fig 4. Substitutions at residues 375, 377 and 380 confer similar effects on clade B LN40, LN8 and clade C Z1792M Envs.
Neutralization profiles for sCD4 (A), 447-52D (B) and b6 (C) are shown. Each substitution had similar effects on the three different Envs.
consistently increasing sensitivity to sCD4. However, only 380P conferred sensitivity to mab b6, while 377V and 380P exposed the V3
loop crown (447-52D epitope), while 375W didn’t. Of note, Z1792M does not carry the 447-52D epitope.
doi:10.1371/journal.ppat.1005988.g004
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The presence of P369, rendered Z1792Mmore sensitive to sCD4 (S9 and S10 Tables), perhaps
indicating an Env trimermore open to nabs and possibly explaining the selective advantage of
L over P at 369 for clade C Envs in patients.
The effects of Env substitutions on the V2q epitope of LN8 and Z1792M
Unlike LN40, LN8 and Z1792M Envs carry the glycan at N160 in V2 and are sensitive to the
trimer specificV2q mabs PG9 and PGT145 [36]. Measuring sensitivity to V2q mabs could help
monitor whether trimers are closed for each mutant. Surprisingly, all LN8 and Z1792M substi-
tutions remained sensitive to PG9 and PGT145, although Envs carrying S375W, N377V and
G380P substitutions in LN8 and Z1792Mwere modestly less sensitive to either PG9, PGT145
or both (Fig 5A and S7–S10 Tables). To verify that the V2q, trimer apex epitope could be dis-
rupted, we measured PG9 binding to LN8 trimeric Envs expressed on 293T cells in the pres-
ence or absence of sCD4.We chose the LN8 S375Wmutant Env for this control experiment
since it is highly sensitive to sCD4 inhibition. S4 Fig shows that prior treatment of the LN8
375Wmutant Env with sCD4 led to a dramatic reduction in PGT145 staining consistent with
the trimer opening and the V2q, trimer apex abrogated.
The modest impact of the S375W, 377V and 380P substitutions on sensitivity to V2q mabs
is curious. How can the LN8 G380P Env trimer be open sufficiently to bind b6 and 447-52D,
yet remain substantially sensitive to V2q mabs, PG9 and PGT145 that recognize closed tri-
mers? One possibility is that PG9 or PGT145 bind open trimers by retaining an interaction
with monomeric gp120. However, using ELISAs, it was confirmed that these mabs do not bind
Z1792M gp120 monomers (S3C Fig). It is therefore likely that the native trimers of mutants
380P and 377V take up a conformation where the PG9, PGT145 epitope in the TAD is largely
maintained while still exposing the V3 loop crown and CD4bs including the b6 epitope (S5A
Fig). However, there is an intriguing alternative where these mutant trimers transition to and
from closed and open forms [37], so that b6 captures the open state, while V2q mabs capture
the closed state (S5B Fig).
Fig 5. Env substitutions in the CD4 binding loop modulate the trimer specific, V2q epitope. (A) Env substitutions proximal to the
Phe-43 cavity, reduced sensitivity to V2q, mabs, PG9 and PGT145, consistent with a more open TAD and trimer. (B) Substitution S365V
on the variable, N-terminal flank of the CD4 binding loop enhanced sensitivity to V2q mab PGT145, consistent with a modified (but not
more open TAD conformation).
doi:10.1371/journal.ppat.1005988.g005
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An S365V substitution in a CD4 contact residue enhanced the V2q
epitope
While substitutions downstream of the GGD-E (366–370) CD4 contact residues, resulted in
changes consistent with TAD and trimer opening,mutations in upstream residues had little
effect on sensitivity to sCD4 and other mabs (Table 1 and S4 and S7–S10 Tables). Exceptions
include N362D, Q363D and Q363E, which enhanced b12 sensitivity for either LN8 or LN40.
An S365V substitution modestly increased sensitivity to both PG9 and PGT145 for
Z1792M. Effects on LN8 were more marginal, although S365V was still the most sensitive LN8
mutant for PG9 and PGT145 (Fig 5B, S7–S10 Tables). The 373E substitution also enhanced
(rather than reduced) the V2q epitope, although less than for S365V.
Investigation of mutant Env trimer conformation in a direct binding assay
Experiments described above exploited neutralization assays with Env-specificmabs to investi-
gate the exposure of different epitopes. However, while mab binding is a critical step for neu-
tralization, other mechanisms may also be involved [38]. We next used a direct mab/trimeric
Env binding assay to confirm critical data for LN8 mutants 375W and 380P. LN8 wt and
mutant Envs were expressed on 293T cells before evaluating mab binding by Flow cytometry.
Data presented shows that binding of CD4-IgG and mabs VRC01, b6, 447-52D, PGT145 and
17b accurately followed neutralizationmeasurements (Fig 6).
Sensitivity to potent CD4bs mabs and macrophage-tropism
The ability of HIV-1 R5 strains to infect macrophages has been shown to reflect an enhanced
Env:CD4 interaction [6, 21, 39, 40]. Several of the Env mutants described above (e.g. 375W,
377V and 380P) were more sensitive to sCD4 inhibition, consistent with a more efficient Env:
CD4 interaction. Neutralization data using CD4bs mabs, b12 and b6 also supported a more
exposedCD4bs for several mutants. We next tested the sensitivity of LN40, LN8 and Z1792M
Env mutants (375W, 377V and 380P) to the highly potent CD4bs mabs, VRC01 and 3BNC117
(S11 Table). These CD4bs mabs bind gp120 monomers as well as closed and open trimers [41,
42]. They both recognize a very broad range of diverse HIV-1 Envs. Here, VRC01 and
3BNC117 mabs neutralized LN8 and LN40 wt Envs as well as 375W, 377V and 380P Env
mutants as expected confirming that the 375W, 377V and 380P Env mutants have not compro-
mised the VRC01-related epitope while exposing the CD4bs. Nonetheless, both LN40 and LN8
mutants showed slightly reduced sensitivity to both VRC01 and 3BNC117 mabs, which prefer-
entially favor binding to tightly packed, closed trimers [41]. These results are consistent with
data from other CD4bs mabs (b12 and b6) and support more open trimers for the mutant
Envs. Z1792M did not bind either VRC01 or 3BNC117. We also tested mab 8ANC195 which
binds to a conserved epitope at the junction of gp120 and gp41 and recognizes both open and
closed trimers [43]. 8ANC195 only recognizedZ1792M, neutralizing wt as well as 375W, 377V
and 380P similarly (S11 Table).
Finally, we tested whether LN40 and LN8 Env mutants (375W and 380P) could trigger
infection of primarymacrophages. Pseudoviruses carryingEnv mutants 375W and 380P
(which exhibit enhanced sensitivity to sCD4), were tested for infection of monocyte-derived
macrophages from three different donors. Each of the mutant Envs mediatedmacrophage
infection, while the wt LN40 and LN8 Envs did not (Fig 7). Nevertheless, the levels of macro-
phage infectionmediated by the mutant Envs were substantially lower than that recorded for
the mac-tropic R5 Env, B33 (from the same subject as LN40 [6, 21]).
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These observations are consistent with a more exposedCD4bs and more efficient Env:CD4
interactions. However, they indicate that further substitutions would be required to confer full
macrophage infectivity.
Discussion
An HIV-1 vaccine that induces potent and broad nabs will require detailed knowledge of the
residues that control the configuration of the Env trimer. This information will help design
Env immunogens that optimally present the best epitopes for eliciting the most rigorous vac-
cine response.
A novel saturation mutagenesis approach, EMPIRIC, was applied to investigate the role of
residues in a 20 amino acid stretch of gp120 in regulating the conformation of the TAD and tri-
mer. This region encompasses the CD4 binding loop and flanking regions. Several residues
were identified that modulated the TAD and trimer (summarized in Table 2, S6 Fig and Movie,
https://vimeo.com/165897330, password: Mama8). However, different residues enhanced Env:
CD4 interactions by imparting distinct TAD conformations with differential exposure of the
V3 loop and other epitopes usually occludedwithin the trimer. The majority of mutations that
modifiedLN40 TAD and trimer had similar effects on LN8 and clade C, Z1792M, indicating
that residues identified, control Env conformation across clades. Several residues in this region
have been examined previously. However, our data represents a large new resource for this
region of Env and greatly extends previous studies. For example, S375F, S375Y and S375W
were studied in the context of monomeric gp120 [5], while 375 substitutions into functional
Env trimers mainly focused on S375W [5, 31]. More recently, Li et al. showed that 375 variants
carrying bulky hydrophobic side chains in SHIV enhanced interactions with macaque CD4 as
well as their replication and pathogenesis in macaques [44].
Mutations likely to affect trimer conformation were identified in competition assays by rep-
lication in PBMCs. This approach selects for mutations that support viral replication in the
absence of nabs and enabled the identification of residues infrequent on the HIV sequence
database. The effect of selectedmutations on Env conformation was then investigated using a
panel of Env mabs which recognized a range of Env epitopes. We focused initially on mabs
that recognized epitopes that are usually occluded on native trimers including 447-52D (V3
loop), b6 (CD4bs) and 17b (CD4i) as well as assessing shifts in sensitivity to sCD4 inhibition.
This approach thus measures the exposure of epitopes and should not be greatly impacted by
librarymutations destroying specificmab epitopes. For example, substitutions 375W, 377V
and 380P were shown to increase CD4 binding and result in more open trimers where usually
occluded epitopes are exposed. Two types of substitution were observed. (1) Substitutions that
modified the local structure around the CD4bs e.g. N362D in LN8, where the b12 epitope was
exposedwithout affecting other sites. (2) Substitutions that modifieddistal sites including V3
and the TAD e.g. S365V, S375W, N377V and G380P. One concern with the competition assay
was whether spontaneous mutations contributed to enhanced replication. This was not investi-
gated. However, many mutations mediated significant effects on the trimer when investigated
individually using pseudoviruses carryingmutant Envs. These observations confirm that
EMPIRIC identifies physiologically relevant amino acid substitutions and is a formidable
Fig 6. Direct binding measurements of CD4-Ig and mabs follows neutralization sensitivity of Env
+ pseudoviruses. LN8 wt, 375W and 380P Envs were expressed on 293T cells before measuring binding of
CD4-Ig and mabs using flow cytometry. Boxed values in the right hand, top corner of each flow profile
represents the neutralization titer for each reagent and shows that binding closely followed neutralization
sensitivity.
doi:10.1371/journal.ppat.1005988.g006
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mutagenesis tool for analyses of Env conformation, fitness or other properties, relevant for
vaccines.
Two libraries were prepared covering residues 361–370, and 371–380 (Fig 1). Library-361-
370 contained the variable N-terminal flank [30] and CD4 contact residues GGD368-E370. Few
Fig 7. Macrophage infection mediated by LN40 and LN8 Env mutants 375W and 380P. Macrophage
infectivity was measured as described in Materials and Methods using monocyte derived macrophages from three
independent donors. 375W and 380P mutants (but not wt) Envs conferred infection of macrophages by Env
+ pseudoviruses. However, infectivity was substantially lower than that of a pseudovirus carrying B33 Env, an R5
mac-tropic Env.
doi:10.1371/journal.ppat.1005988.g007
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mutants from this library were identified that increased replicative capacity over wt virus or
conferred a more open Env conformation. Nevertheless, many variant residues on the N-termi-
nal flank conferred wt-like replication, contrasting with mutations in conservedCD4 contact
residues wherewt residues predominated during PBMC replication (Fig 2B and 2C). These
observations indicate that these latter amino acids have been highly selected during evolution
as would be predicted for sites contacting a major receptor. The lack of beneficialmutants in
the variable 361–365 region was curious, since a motif on this variable flank region was previ-
ously identified that influenced the non-mac-tropic phenotype of LN40 Env [8]. However, this
motif required the presence of further determinants in V3 to mediate maximal effects on LN40
Env properties [8].
A small number of substitutions on the N-terminal flank did affect Env properties. LN40
Q363D and Q363E mutants were more sensitive to the CD4bs mab, b12, with more modest
effects on sCD4, 447-52D and 2G12 sensitivity detected. The 365V substitution conferred a
small (not significant) increase in replication for LN40 Env+ virus in PBMCs. When intro-
duced into other Envs, an increase in sensitivity to the trimer apex mabs, PG9 and PGT145,
was detected for Z1789M (and more marginally for LN8) consistent with effects on the confor-
mation of the TAD but without detectable opening of the trimer.
Residue 369 is a relatively conserved residue situated betweenCD4 contact residues
(GGDP369E) at the tip of the CD4 binding loop. There is some clade specificity to this residue
i.e. P in clades B and D, L in clades A and C. In clade B LN40, several substitutions were toler-
ated without detectable effects on Env properties. In contrast, an L369P substitution in clade C
Z1792M resulted in an enhanced sensitivity to sCD4 consistent with increased exposure of the
CD4bs. These data suggest that variation at residue 369 is selected against in vivo as it may
result in increased exposure of the CD4bs to nabs, at least for clade C. However, no insights
were obtained into the selective pressures that prevent 369 variation in clade B.
Several residues in library-371-380 could be replaced by residues that enhanced replication
in PBMCs. These residues had strong effects on the conformation of the trimer and TAD as
indicated by significant increases in sensitivity to sCD4, CD4bs mabs b6 and b12, and to V3
crown mab 447-52D depending on substitution. The positions in 371–380 are each closely
Table 2. Summary of Env mutations that affect trimer conformations.
Env region Substitution Specificity Affected Env region
CD4bs V3 loop1 TAD V2q epitope2 2G12
glycans




not tested not tested
CD4 binding loop, N-
terminal flank
362D LN8 specific mab b12 epitope more exposed hidden no effect shifted
363D LN40 specific mab b12 epitope more exposed more
exposed
not tested shifted
365V Z1792M, LN8 more
marginal
No effect still hidden enhanced
presentation
no change
Phe-43 cavity 375W cross clade3 more exposed still hidden reduced shifted
CD4 binding loop, C-
terminal flank
377V cross clade3 more exposed exposed reduced shifted
380P cross clade3 more exposed highly
exposed
reduced shifted
1 Not tested on Z1792M.
2 Not tested on LN40
3 V3 exposure not tested on clade C, Z1792M
doi:10.1371/journal.ppat.1005988.t002
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associated with the Phe-43 cavity and likely play a role in controlling Env conformational
changes in response to CD4 binding [3, 4].
Residues that altered the TAD and trimer conformations had different effects on the expo-
sure of mab epitopes. Several residues in the 371–380 region conferred enhanced sCD4 sensi-
tivity, yet affected exposure of the 447-52D V3 and b12 epitopes differently. Thus, G380P
increased sensitivity to sCD4 in LN40, LN8 and Z1792M, and also imparted greatly enhanced
sensitivity to 447-52D for both LN40 and LN8. However, while G380P conferred sensitivity to
b12 for LN8, there was little effect for LN40. S375W, S375Y and S375F mediated increases in
sCD4 sensitivity for LN40, but had no effect on 447-52D resistance. Thus different residues
associated with the Phe-43 cavity, regulate distinct conformations of the TAD at the trimer
apex and highlight a potential role for this region in regulating immune protection. It is also
worth noting that the 375W, 377V and 380P substitutions did not affect the integrity of the
VRC01/3BNC117 CD4bs epitope, a highly desirable target for the induction on potent neutral-
izing antibodies. Together, these observations thus have relevance for vaccine development,
where Env trimers fine-tuned for enhanced exposure of the CD4bs but without exposing irrele-
vant immunogenic sites (e.g. the V3 loop) that are occluded on primary Envs are desired
immunogens.
For several mutants that had modifiedTAD and/or trimers with enhanced exposure of the
CD4bs, it was noted that sensitivity to 2G12 was reduced.Mab 2G12 recognizes several glycans
on gp120 and its ability to bind and neutralize virions depends on their orientation. Reduced
sensitivity to 2G12 suggests that modified,more open Envs have shifted the glycans forming
this mab’s epitope as previously reported [19].
The glycan N160 in V2 is a target for V2q antibodies and its lack explains why LN40 Env is
insensitive to PG9 and PGT145 mabs. This was unfortunate since V2q mabs can be used to
investigate changes in TAD configuration. Introduction of the potential glycan site at N160 in
LN40 Env failed to restore sensitivity to V2q mabs. However, the presence of the glycan site at
N160 increased sensitivity to sCD4 and V3 mab, 447-52D. These observations indicate that in
the context of LN40, N160 modified the trimer conformation, exposing the V3 loop and
increasing access for CD4. N160 also enhanced the effects of other substitutions on Env confor-
mation. For example, 373E, 377V and 380P were all more sensitive to V3 loopmab, 447-52D
in the presence of N160. N160 on LN40 may loosen the TAD and facilitate some substitutions
to confer more extensive shifts in conformation. It is worth noting that the presence of N160
had only marginal effects on the S375W substitution, with low level 447-52D neutralization
detected and sCD4 inhibition slightly enhanced. These observations add further support to the
conclusion that S375 substitutions induce a trimer conformation distinct from those imposed
by other substitutions e.g at 377, 380. The increased exposure of the CD4bs and V3 loop fol-
lowing the introduction of an N160 glycan to LN40 is curious. It suggests that LN40 Env
evolved a distinct native conformation that is unfavorable for an N160 glycan. It would be
interesting to assess whether other primary Env trimers that lack an N160 glycan, also expose
the usually protected CD4bs, V3 epitopes if one is introduced.
It was surprising that several mutant LN8 and Z1792M Env trimers were sufficiently open
to bind mabs b6 and (for LN8 mutants) 447-52D, yet remained sensitive to V2q mabs (that
predominantly recognize closed trimers), albeit with modestly increased IC50s. It is therefore
likely that some substitutions can expose the b6 epitope in the CD4bs region as well as the 447-
52D epitope without significantly opening the TAD (S5 Fig). However, an intriguing alterna-
tive explanation is that Envs transition from closed to open states and back, so that mabs b6
and 447-52D capture the open form, while the V2q mabs capture the closed form.
LN40, LN8 and Z1792Mwt Envs are non-mac-tropic and require high levels of cell surface
CD4 to trigger fusion and entry. The enhanced Env: CD4 interactions detected for several Env
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mutants would be expected to increased their capacity to mediatedmacrophage infection. This
possibility was evaluated for LN40 and LN8 375W and 380P substitutions with a modest
enhancement of macrophage infection observed.However, this level of macrophage infection
was substantially lower in comparison to that conferred by a highly mac-tropic brain R5 Env
(B33). This result indicates that furthermutations would be required for a full mac-tropic phe-
notype.Whether, such additional mutations would further enhance Env: CD4 interactions or
affect macrophage infection via a distinct mechanism is unclear.
In summary, mutations in the CD4 binding loop and flanks that affect trimer conformation
were identified in replication competition assays. Different substitutions identifiedwere associ-
ated with distinct conformations that impacted on the exposure of the V3 loop and TAD, the
CD4bs and the efficiencyof CD4 interactions in Envs from different clades. The information
presented contributes to the establishment of universal, cross clade rules for regulating trimer
conformation and will be invaluable in the design of next generation Env immunogens.
Materials and Methods
Construction of plasmid-encoded libraries
Env saturation mutant libraries were generated using a previously described approach [13, 15].
Briefly, the env gene was cloned into pRNDM to generate a plasmid without BsaI restriction
sites. Inverted BsaI sites were then introduced to allow for a cassette ligation strategy with each
single codon randomized as NNN to efficiently generate libraries of all possible codon substitu-
tions; a separate cassette was used to mutate each codon to all 63 non-parental ones. Libraries
of single codonmutants at 10 consecutive codons were combined and the resulting pool trans-
ferred from pRNDM to replication competent pNL4.3 with LN40 env, using sequence and liga-
tion independent cloning (SLIC) [45]. A SLIC destination vector was generated that encoded
the HIV genome with the majority of the env gene removed and a unique BmtI restriction site
at this location. The destination vector was digested with BmtI and resectedwith T4 DNA
polymerase as describedpreviously [45] to leave approximately 30 bases of single stranded
DNA at each end. Linear fragments of the env libraries from pRNDMwith single stranded
regions matching the prepared destination vector were generated by PCR (using Pfusion high
fidelity polymerase and eight cycles of amplification to minimize amplification errors) and
treatment with T4 DNA polymerase. The prepared library and destination DNA were mixed at
equal molar amounts, annealed for 30 minutes at 37°C, and transformed into bacteria to gener-
ate the plasmid libraries encoding full-length viral genomes.
Viral library recovery and competition experiments
2.5 μg of DNA encoding full length NL4.3 carrying LN40 or 361–370 and 371–380 mutant
library envelopes were transfected into 293T cells using calcium phosphate. Supernatants car-
rying full length NL4.3-LN40env or libraries (P0) were harvested 48 h after transfection, clari-
fied (1,000g for 10 min), aliquoted, and stored at -152°C. HeLa TZM-bl cells were used to
titrate the P0 stock libraries using the LTR-controlled β-galactosidase reporter gene to identify
infected cells as describedpreviously [46].
20x106 PHA treated peripheral bloodmononuclear cells (PBMCs) were recovered from a
frozen stock and infected with 2 ml wild type (wt) LN40 virus, or with each library virus stock
(P0) in duplicate. After 3 hours, infected PBMCs were centrifuged at 1200 rpm for 10 min.
Supernatant was harvested and frozen as day 0 (D0). Cells were washed with 5ml of RPMI/
10% fetal calf serum twice before adding 10 ml RPMI/10% fetal calf serumwith IL-2 (Roche
Inc.). Medium was changed after 4 days and supernatants collected on day 8. 200 μl samples
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were treated with recombinant DNase I for 2h at room temperature to eliminate any carry over
of plasmid DNA before extracting RNA using the High Pure viral RNA kit (Roche Inc.).
Sequence analyses and estimation of fitness
HIV genomic RNA was extracted from supernatants containing virions using High Pure Viral
RNA kit (Roche Inc.). Viral RNA was reverse transcribed into cDNA using primers binding
downstream of randomized libraries and SuperScript III (Life Technologies Inc.). Subsequent
processing steps were as describedpreviously for analyzing mutant frequency [13]. Briefly,
samples were barcoded to distinguish replicates as well as plasmid, P0, and P1 samples and
submitted for Illumina 36bp single read sequencing on a Genome Analyzer II. Reads with a
phred score of 20 or above (>99% confidence across all 36 bases) were analyzed (S12 Table).
The relative abundance (A) of each point mutant of plasmid, P0 and P1 library was estimated







The frequency change (F) of a mutation from P0 to P1 (Eq 2) was used as an estimate of the
enrichment or depletion during viral expansion. Two replicates of P1 were determined sepa-
rately.
F ¼ AP1   AP0 ðEq: 2Þ
Selection coefficients (s) representing the experimental effects of each mutation were calcu-
lated by normalizing the median of stop codon to -1 (representing null fitness) and wild-type





The above analyses yielded estimates of fitness effects for each codon with frequency>
0.015% in the P0 library (S12 and S13 Tables). Mutations below this frequency in P0 were likely
subject to highly stochastic sampling in the pool of viruses used to start P1 passages. These
mutations (4% of the data) also had very low frequency in the plasmid library. The high corre-
lation between frequency of mutants in P0 and the plasmid library suggested that viral recovery
by transfection provided sufficient sampling of mutants in the plasmid library (S1E Fig), so
mutants with low frequency in P0 library was due to their inherent low frequency in the plas-
mid library and not due to a bottleneck effect or selection in viral recovery.
As estimates of selection coefficient (s) had some noise, in particular in the 361–370 library
(S2C and S2D Fig), the median of s of synonymous codons encoding the same amino acid was
used to represent s of that amino acid, to minimize impact from outliers. RMSD was deter-
mined between the two replicates to estimate variation in s of amino acids. The two replicates
in P1 were then pooled to estimate the selection coefficient of amino acids to further improve
reproducibility. Specifically, the median was computed for s of all synonymous codons encod-
ing the same amino acid in both replicates as s for that amino acid (S1 Table).
To determine whether a mutant is statistically beneficial, or wt -like, or deleterious, the s of
each amino acid was compared to the median of s of resampled wt -synonyms, and defined
mutants with s significantly greater than that of wt -synonyms as beneficial;mutants with s sig-
nificantly less than that of wt-synonyms as deleterious and the rest as wt -like. Allwt-synonyms
of both replicates were pooled for each library (38 for Library-361-370 library and 50 for
Library-371-380 library). For each amino acid, wt-synonyms were resampled as twice the
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number of synonymous codons encoding that amino acid and compared the median of s of
resampled wt-synonyms with s of that amino acid. This process was repeated 10,000 times for
each amino acid and computed the proportion (f)when s of amino acid is greater than median
s of resampled wt -synonyms. 1-f (if f>0.5) or f (if f< = 0.5) is the empirical p value of this
amino acid having a fitness effect greater than or less than wt -synonyms. Before multiple test
corrections,mutants with p value<0.025 have a significantly different s with wt -synonyms
(S1 Table). A two-sided 5% False Discovery Rate (FDR) was then applied as multiple test cor-
rection. After that, amino acid mutants with a sufficiently small p value were classified as statis-
tically beneficial or deleterious and the rest as statisticallywt -like. False negative rates were not
estimated, so that a small number of mutants that were classified as wt-likemight be beneficial
or deleterious. Amino acids with more synonymous codons were treated as having more repli-
cates so that they would have stronger statistical power in classification.
Cloning of individual mutants
A panel of individual gp120 mutations were cloned into the pSVIIIenv vector that carried clade
B LN40, LN8 or clade C Z1792M env genes and analyzed in isolation. A cassette with a single
mutant was ligated into BsaI digested pRNDM, as described above, and then subcloned into
pSVIIIenv. For LN40 env, one KpnI site in pSVIIIenv vector outside env coding region, was
eliminated with quick change mutagenesis. pRNDMwith mutants and pSVIIIenv were both
digested by KpnI and SpeI, and the mutant fragments from pRNDM ligated into digested
pSVIIIenv. For LN8 env, two sets of primers were utilized to generate two fragments of env by
PCR. The 3’ region of one fragment shared a 27-nucleotide homologous region with the 5’
region of the other fragment, and the 3 nucleotides in the middle of the homologous region
were mutated to desiredmutations by PCR. Primers are described in S14 Table. pSVIIIenv was
digested by KpnI and SpeI, followed by T4 polymerase trimming to generate matched ends
ready for homologous recombination. The digested vector and the two PCR generated frag-
ments were then assembled back into the full length pSVIIIenv vector through Gibson assem-
bly to generate a set of mutants (New England Biolabs, Ipswich, MA).
HIV Env clones, sCD4 and monoclonal antibodies
EMPIRIC libraries were cloned into pNL4.3 carrying the LN40 env gene. A version of LN40
env was used that was chimeric with LN40 gp120 and gp41 sequences derived from the B33, a
brain env derived from the same subject as LN40. This chimeric Env is non-mac-tropic and
carries determinants and properties of non-mac-tropism in gp120 as reported previously [6–8,
21].
Soluble CD4 was from Progenics Inc. Monoclonal antibodies (mabs) PG9, PG16 (V2q), b12
(CD4bs), 447-52D (V3 loop) and 2G12 (glycans) were from Polymun Scientific Inc. (Austria).
PGT145 (V2q) and VRC01 (CD4bs) were prepared in house. Mab b6 (CD4bs) was provided
by Dennis Burton (Scripps Research Institute), mab 17b (CD4i) by George Lewis (Institute of
Human Virology) and mab PGT128 (V3, glycans) was provided by IAVI. 3BNC117 [42] was
provided by the NIH AIDS Reagent Program.
Preparation of Env+ pseudoviruses
Env+ pseudotypes were produced and titrated as describedpreviously [6, 21, 24, 47]. Briefly,
Env+ pSVIIIenv constructs carrying different single mutations were cotransfected into 293T
cells with env-minus pNL43. Env+ pseudovirions were harvested after 48 hours, clarified by
low speed centrifugation and frozen as aliquots at -152°C. Env+ pseudovirions were titrated on
HeLa TZM-bl cells cells, which carry β-galactosidase and luciferase reporter genes controlled
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by HIV LTR promoters [46]. Infected cells were visualized 48 hours after infection as focus
forming units (FFU) following staining for β-galactosidase activity. Since Env+ pseudovirions
are only capable of a single round of replication, individual cells or small groups of divided
cells were counted as foci.
Antibody neutralization assays and IC50 determination
Neutralization and inhibition assays were performed as describedpreviously using 200 FFU of
Env+ pseudovirus and evaluating residual infectivity on HeLa TZM-bl cells via a luminescence
readout [7, 30].
Detection of the epitope of mab 17b on monomeric gp120 by ELISA
Production and measurement of LN40 gp120 concentration: Monomeric LN40 wt gp120 was
prepared by transfection of pJW4303-LN40 gp120 into 293T cells using 293Fectin (Thermo
Fisher Scientific Inc.). Cell supernatant was harvested 72 hours after transfection and purified
by lectin column chromatography [48]. The concentration of gp120 was estimated by titration
using a capture enzyme-linked immunosorbent assay (ELISA) by comparing the half maximal
binding dilution of LN40 gp120 to a standard concentration of IIIB gp120 [49].
Mab 17b binding to monomeric gp120: 17b binding to LN40 gp120 was evaluated using a
modified capture ELISA. Briefly, saturating amounts of LN40 gp120 were captured onto ELISA
plates treated with sheep anti-gp120 antibody (Aalto Bio Reagents Inc.) [30, 49], before testing
17b (5 μg/ml) binding in the presence of increasing concentrations of sCD4.
Expression of Env trimers on 293T cells and mab binding
HIV-1 Envs were expressed on 293T cells following transfection of Env expression vectors
using Fugene6 following the manufacturer’s protocol. Briefly, Envs were expressed from
pSVIIIenv by co-transfectingwith pSV2-Tat72 and pGEMfurin [50]. Env expression was eval-
uated 2 days post transfection using a panel of Env mabs to distinguish the predominant
expression of cleaved trimeric Env over uncleaved or defective Env forms [50]. In particular,
mabs PG9 and PGT145 (V2q, trimer specific), 447-52D (V3 loop), b6 (CD4bs), 17b (CD4i)
were used to detect closed trimers where the V3 loop and CD4i epitopes are occluded [50]. We
also tested several other mabs as described above, as well as CD4-Ig. Binding of these human
mabs and CD4-Ig was detectedwith an anti-human IgG-FITC conjugate and examined by
flow cytometry in the University of Massachusetts Medical School Flow Cytometry Core.
Preparation of primary macrophages and their infection
5x107 peripheral bloodmononuclear cells (PBMCs) from a buffy coat (New York Biologics)
were plated into 14-cm bacterial culture dishes for 3 h before extensively washing away non-
adherent cells, culturing overnight, and repeating the washes. The adheredmonocytes were
then cultured for 5 to 7 days in 10% AB+ human plasma in DMEM before treatment with
EDTA and transfer to 48-well tissue culture dishes the day prior to infection seeding at 1.25 x
105 cell/well [6, 21, 24].
Macrophage infectivity of Env+ pseudoviruses carrying LN8 and LN40 wt and mutant
(375W and 380P) Envs was assessed on duplicate wells of 3 batches of macrophages prepared
from independent donors. Macrophages (seeded in 48 well plates) were pretreated with 100 μL
DEAE dextran (10 μg/mL) in DMEMmedium containing 10% human plasma for 30 min at
37°C before Env+ pseudoviruseswere added at 100 μL/well. Infected plates were spinoculated
for 45 min at 1,200 RPM in a benchtop centrifuge at room temperature [51, 52]. Infected
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macrophages were incubated for a further 3 h at 37°C before the addition of 300 μL of DMEM
(10% human plasma) and incubating at 37°C for 7 days. DEAE dextran and spinoculation
enhance virus infectivity by approximately 20-fold by increasing attachment [51] and entry
[52]. Env+ pseudovirions are capable of only a single round of replication so that focus-forming
units (FFU) were estimated 5–7 days post-infectionby counting infectedGFP+macrophages
by fluorescent microscopy.
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